| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/22/2004 | CA2492038A1 Transgenic bioluminescent plants |
| 01/22/2004 | CA2491984A1 Nucleic acid amplification method |
| 01/22/2004 | CA2491805A1 Modified adenoviral fiber with ablated binding to cellular receptors |
| 01/22/2004 | CA2491704A1 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | CA2491279A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | CA2491235A1 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | CA2491234A1 Use of a gene for increasing the oil content in plants |
| 01/22/2004 | CA2491223A1 Chromosome 6 and 9 genes involved in premature canities |
| 01/22/2004 | CA2489174A1 Rna-interference by single-stranded rna molecules |
| 01/22/2004 | CA2483524A1 Electroporation method including the use of depressurization/pressurization |
| 01/22/2004 | CA2433479A1 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 01/21/2004 | EP1382969A1 Diagnosis and prevention of cancer cell invasion |
| 01/21/2004 | EP1382693A1 Methods and compositions for the detection of pathologic events |
| 01/21/2004 | EP1382692A2 Enzymatic assay of HIV protease inhibitors |
| 01/21/2004 | EP1382688A1 Screening method |
| 01/21/2004 | EP1382684A1 Process for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 01/21/2004 | EP1382683A2 Process for producing 3-hydroxycyclohexanone |
| 01/21/2004 | EP1382682A2 Modulating developmental pathways in plants |
| 01/21/2004 | EP1382681A1 A modified CBD/RGD recombinant attachment factor for improving cell-attachment efficiency and the manufacturing method thereof |
| 01/21/2004 | EP1382680A1 1,3-galactose transferase and dna encoding the enzyme |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382678A1 Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same |
| 01/21/2004 | EP1382677A1 A method for separating and purifying a nucleic acid |
| 01/21/2004 | EP1382676A1 A method for separating and purifying a nucleic acid |
| 01/21/2004 | EP1382675A1 A method for separating and purifying a nucleic acid |
| 01/21/2004 | EP1382674A2 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382615A1 MCAM inhibitors |
| 01/21/2004 | EP1382612A1 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382386A2 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| 01/21/2004 | EP1382348A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/21/2004 | EP1382345A2 Uses of inhibitors of hemostasis |
| 01/21/2004 | EP1381860A2 Models and methods for determining systemic properties of regulated reaction networks |
| 01/21/2004 | EP1381698A2 Method for analysing nucleic acid chains |
| 01/21/2004 | EP1381697A2 Circular probe amplification (cpa) using energy-transfer primers |
| 01/21/2004 | EP1381696A2 Method to analyse the kit genotype of pigs |
| 01/21/2004 | EP1381695A2 Methods of analysis of nucleic acids |
| 01/21/2004 | EP1381693A1 Apparatus and method for sequencing a nucleic acid |
| 01/21/2004 | EP1381691A2 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 01/21/2004 | EP1381687A2 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381685A2 Genes and proteins for the biosynthesis of polyketides |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381683A2 Human fibroblast growth factor-related compositions |
| 01/21/2004 | EP1381682A2 Modulators of leukocyte activation, compositions and methods of use |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381680A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| 01/21/2004 | EP1381679A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381677A2 Neurotoxins with enhanced target specificity |
| 01/21/2004 | EP1381676A2 Nucleic acid molecules encoding starch degrading enzymes |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381674A2 Method for generating highly active human dendritic cells from monocytes |
| 01/21/2004 | EP1381673A1 Compositiona and methods useful for hcv infection |
| 01/21/2004 | EP1381672A1 Biosynthesis of polyketide synthase substrates |
| 01/21/2004 | EP1381631A2 Human timp-1 antibodies |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381410A2 Methods of isolating blood components using a centrifuge and uses thereof |
| 01/21/2004 | EP1381388A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 01/21/2004 | EP1381375A2 Oligonucleotide compositions and their use to induce differentiation of cells |
| 01/21/2004 | EP1381345A2 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP1381276A2 Method of treating or retarding the development of blindness |
| 01/21/2004 | EP1381268A2 Method for modifying plant biomass |
| 01/21/2004 | EP1381267A2 Transgenic plants containing altered levels of steroid compounds |
| 01/21/2004 | EP1381266A2 Tomato plants that exhibit resistance to $i(botrytis cinerea) |
| 01/21/2004 | EP1242129B1 Biological joint construct |
| 01/21/2004 | EP1010007B1 Collagen-peptide assay method |
| 01/21/2004 | EP0977596B1 Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells |
| 01/21/2004 | EP0904362B1 Method for transforming plant tissue |
| 01/21/2004 | EP0863982B1 Synthetic hpv11 virus-like particles |
| 01/21/2004 | EP0842276B1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv) |
| 01/21/2004 | EP0830376B1 Process for producing erythropoietin containing no animal proteins |
| 01/21/2004 | EP0728213B1 Transgenic fructan accumulating crops and methods for their production |
| 01/21/2004 | EP0695349B1 Enzymes with xylanase activity from aspergillus aculeatus |
| 01/21/2004 | EP0516664B1 Transgenic animals, cells and cell lines therefrom, and their use |
| 01/21/2004 | CN1469931A Plant-signalling ligand like proteins |
| 01/21/2004 | CN1469930A Cytomegalovirus intron a fragments |
| 01/21/2004 | CN1469929A Method of modifying microorganism-origin transglutaminase |
| 01/21/2004 | CN1469928A Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
| 01/21/2004 | CN1469927A Enhancemnet of industrial production by increasing substrate transport |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469775A Particulate support for separation/purification or extraction and process for producing the same |
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |
| 01/21/2004 | CN1469739A Method for modulating bladder function |
| 01/21/2004 | CN1469705A Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 01/21/2004 | CN1468963A Construction and application of gene engineering strain of Harpin protein expressing colibacillus |
| 01/21/2004 | CN1468962A Expression and purification of small envelope protein of soluble SARS virus |
| 01/21/2004 | CN1468961A Expression and purification of soluble SARS virus 3CL proteinase |
| 01/21/2004 | CN1468960A Production process of human lysozyme as AIDS treating medicine with plant as bioreactor |
| 01/21/2004 | CN1468959A Spatial conformation model of SARS coronavirus protein and its application |
| 01/21/2004 | CN1468958A Synthesis and high-efficiency expression method of bivalent foot-and-mouth disease polypeptide vaccine |
| 01/21/2004 | CN1468957A Plasmid used as human therapeutic vaccine adjuvant |
| 01/21/2004 | CN1468956A Recombinant virus of antibody for high-efficiency expression to treat tumor and its use |
| 01/21/2004 | CN1468953A High-efficiency expression in Pichia yeast, fermentation and purification of human gamma-interferon |